相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibition of proteasome activity promotes the correct localization of disease-causing α-sarcoglycan mutants in HEK-293 cells constitutively expressing β-, γ-, and δ-sarcoglycan
Stefano Gastaldello et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Are big muscles necessarily good muscles?
Amelie Nadeau et al.
ANNALS OF NEUROLOGY (2008)
Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)
Paul Thornhill et al.
BRAIN (2008)
A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice
Kazuhiro Kobuke et al.
HUMAN MOLECULAR GENETICS (2008)
Mannosidase I inhibition rescues the human α-sarcoglycan R77C recurrent mutation
Marc Bartoli et al.
HUMAN MOLECULAR GENETICS (2008)
Animal models for genetic neuromuscular diseases
Mariz Vainzof et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C
Sasha Bogdanovich et al.
MUSCLE & NERVE (2008)
Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A
Emma J. Groen et al.
BRAIN (2007)
LGMD2I in a North American population
Peter B. Kang et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
Dysfunction of dysferlin-deficient hearts
Katrin Wenzel et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Dysferlin, dystrophy, and dilatative cardiomyopathy
Friedrich C. Luft
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I
N. Darin et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency
M. Bartoli et al.
GENE THERAPY (2007)
145th ENMC International Workshop: Planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD) - 22-24th October 2006, Naarden, the Netherlands
K. Bushby et al.
NEUROMUSCULAR DISORDERS (2007)
Sarcoglycanoplathies: A clinico-pathological study
A. K. Meena et al.
NEUROLOGY INDIA (2007)
Zebrafish orthologs of human muscular dystrophy genes
Leta S. Steffen et al.
BMC GENOMICS (2007)
Modeling human muscle disease in zebrafish
Jeffrey R. Guyon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)
Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF
Alexander Diers et al.
NEUROMUSCULAR DISORDERS (2007)
Endurance training - An effective and safe treatment for patients with LGMD2I
M. -L. Sveen et al.
NEUROLOGY (2007)
Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy
Caroline Godfrey et al.
ANNALS OF NEUROLOGY (2006)
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors
G. C. Minetti et al.
NATURE MEDICINE (2006)
Cardiac involvement in limb-girdle muscular dystrophy 2I - Conventional cardiac diagnostic and cardiovascular magnetic resonance
C. Gaul et al.
JOURNAL OF NEUROLOGY (2006)
Short-term treatment using insulin-like growth factor-1 (IGF-1) improves life expectancy of the delta-sarcoglycan deficient hamster
Armelle Serose et al.
JOURNAL OF GENE MEDICINE (2006)
δ-sarcoglycan is necessary for early heart and muscle development in zebrafish
Lu Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy
Stephanie A. Parsons et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
High prevalence and phenotype-genotype correlations of limb girdle muscular dystrophy type 21 in Denmark
ML Sveen et al.
ANNALS OF NEUROLOGY (2006)
Calpain-3 mutations in Turkey
B Balci et al.
EUROPEAN JOURNAL OF PEDIATRICS (2006)
Safety and efficacy of AAV-mediated calpain 3 gene transfer in a mouse model of limb-girdle muscular dystrophy type 2A
M Bartoli et al.
MOLECULAR THERAPY (2006)
Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters
H Kondoh et al.
CARDIOVASCULAR RESEARCH (2006)
Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish
LM Kunkel et al.
JOURNAL OF HUMAN GENETICS (2006)
Nonmolecular treatment for muscular dystrophies
K Bushby et al.
CURRENT OPINION IN NEUROLOGY (2005)
Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells
Y Iwata et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Zebrafish as a model for caveolin-associated muscle disease;: caveolin-3 is required for myofibril organization and muscle cell patterning
SJ Nixon et al.
HUMAN MOLECULAR GENETICS (2005)
Basement membrane fragility underlies embryonic lethality in fukutin-null mice
H Kurahashi et al.
NEUROBIOLOGY OF DISEASE (2005)
Effects of fukutin deficiency in the developing mouse brain
T Chiyonobu et al.
NEUROMUSCULAR DISORDERS (2005)
LGMD2A:: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene
A Sáenz et al.
BRAIN (2005)
δ-Sarcoglycan is required for early zebrafish muscle organization
JR Guyon et al.
EXPERIMENTAL CELL RESEARCH (2005)
Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster
A Serose et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
The most common mutation in FKRP causing limb girdle muscular dystrophy type 21 (LGMD21) may have occurred only once and is present in hutterites and other populations
P Frosk et al.
HUMAN MUTATION (2005)
FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients -: art. no. e50
MC Walter et al.
JOURNAL OF MEDICAL GENETICS (2004)
Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality
T Willer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?
J Pouly et al.
CIRCULATION (2004)
Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency
M Ho et al.
HUMAN MOLECULAR GENETICS (2004)
LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies
R Barresi et al.
NATURE MEDICINE (2004)
Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro
I Kramerova et al.
HUMAN MOLECULAR GENETICS (2004)
Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters
M Iwase et al.
CARDIOVASCULAR RESEARCH (2004)
Cardiac and respiratory failure in limb-girdle muscular dystrophy 21
M Poppe et al.
ANNALS OF NEUROLOGY (2004)
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo
DI Bassett et al.
DEVELOPMENT (2003)
The zebrafish as a model for muscular dystrophy and congenital myopathy
DI Bassett et al.
HUMAN MOLECULAR GENETICS (2003)
Efficient and long-term intracardiac gene transfer in δ-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors
J Li et al.
GENE THERAPY (2003)
The 10 autosomal recessive limb-girdle muscular dystrophies
M Zatz et al.
NEUROMUSCULAR DISORDERS (2003)
Treatment for the here and now - cardiac and respiratory management in muscular dystrophy
K Bushby
NEUROMUSCULAR DISORDERS (2003)
Cell therapy of α-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts
M Sampaolesi et al.
SCIENCE (2003)
Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development
S Takeda et al.
HUMAN MOLECULAR GENETICS (2003)
Force impairment in calpain 3-deficient mice is not correlated with mechanical disruption
F Fougerousse et al.
MUSCLE & NERVE (2003)
The phenotype of limb-girdle muscular dystrophy type 2I
M Poppe et al.
NEUROLOGY (2003)
Phenotypic spectrum associated with mutations in the fukutin-related protein gene
E Mercuri et al.
ANNALS OF NEUROLOGY (2003)
Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: Effects on lefy ventriclar geometry and function
N Ohno et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Clinical variability in calpainopathy: What makes the difference?
F de Paula et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies
DE Michele et al.
NATURE (2002)
Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria
T Mongini et al.
NEUROPEDIATRICS (2002)
Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters
T Kawada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria
R Cagliani et al.
NEUROMUSCULAR DISORDERS (2001)
The phenotype of calpainopathy: diagnosis based on a multidisciplinary approach
C Pollitt et al.
NEUROMUSCULAR DISORDERS (2001)
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies
L Politano et al.
NEUROMUSCULAR DISORDERS (2001)
Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations
I Mahjneh et al.
NEUROMUSCULAR DISORDERS (2001)
Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy
SN Illarioshkin et al.
NEUROLOGY (2000)
Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients
F Calvo et al.
NEUROMUSCULAR DISORDERS (2000)
Muscular dystrophy due to dysferlin deficiency in Libyan Jews - Clinical and genetic features
Z Argov et al.
BRAIN (2000)
Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A
K Tagawa et al.
HUMAN MOLECULAR GENETICS (2000)
Homogeneous phenotype of the gypsy limb-girdle MD with the γ-sarcoglycan C283Y mutation
L Merlini et al.
NEUROLOGY (2000)
Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
M Durbeej et al.
MOLECULAR CELL (2000)
分享论文
